Original ResearchGTF-231, a Mixture of Gymnemic acid (cas 1399-64-0), Trigonelline and Ferulic Acid Significantly Ameliorates Oxidative Stress in Experimental Type 2 Diabetes in Rats
-
Add time:09/07/2019 Source:sciencedirect.com
ObjectivesAccording to a report by the United States National Health and Nutrition Examination Survey, nearly 60% of patients with diabetes have more than one complication caused by chronic diabetes. Type 2 diabetes is a multifactorial metabolic disorder that accounts for more than 95% of people with diabetes and usually requires multitargeted therapeutic interventions. It arises due to insufficient insulin secretion or its action or both. Recently, we reported that the oral administration of gymnemic acid, trigonelline and ferulic acid in the ratio of 2:3:1 (GTF-231), a mixture of 3 phytoingredients at a concentration of 300 mg/kg body weight significantly improved the glucose homeostasis in rats with low-dose streptozotocin-induced type 2 diabetes that were fed with high-fat diet.
We also recommend Trading Suppliers and Manufacturers of Gymnemic acid (cas 1399-64-0). Pls Click Website Link as below: cas 1399-64-0 suppliers
Prev:Molecular decodification of Gymnemic acid (cas 1399-64-0)s from Gymnema sylvestre. Discovery of a new class of liver X receptor antagonists
Next:Improvement of growth and Gymnemic acid (cas 1399-64-0) production by altering the macro elements concentration and nitrogen source supply in cell suspension cultures of Gymnema sylvestre R. Br) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Gymnemic acid (cas 1399-64-0)s inhibit rabbit glyceraldehyde-3-phosphate dehydrogenase and induce a smearing of its electrophoretic band and dephosphorylation09/09/2019
- Improvement of growth and Gymnemic acid (cas 1399-64-0) production by altering the macro elements concentration and nitrogen source supply in cell suspension cultures of Gymnema sylvestre R. Br09/08/2019
- Molecular decodification of Gymnemic acid (cas 1399-64-0)s from Gymnema sylvestre. Discovery of a new class of liver X receptor antagonists09/06/2019
- Document headingPharmacological and analytical aspects of Gymnemic acid (cas 1399-64-0): a concise report09/05/2019
- Effects of Gymnemic acid (cas 1399-64-0)s lozenge on reward region response to receipt and anticipated receipt of high-sugar food09/04/2019
- ReviewBinding properties between human sweet receptor and sweet-inhibitor, Gymnemic acid (cas 1399-64-0)s09/03/2019
- Arylated Gymnemic acid (cas 1399-64-0)s from Gymnema sylvestre R.Br. as potential α-glucosidase inhibitors09/02/2019
- New olean-15-ene type Gymnemic acid (cas 1399-64-0)s from Gymnema sylvestre (Retz.) R.Br. and their antihyperglycemic activity through α-glucosidase inhibition09/01/2019
-
Health and Chemical more >


